The epidemiology of childhood cardiomyopathy in Australia

New England Journal of Medicine

Volumn 348, Issue 17, 2003, Pages 1639-1646

  Nugent, Alan W ^a   Daubeney, Piers E F ^a   Chondros, Patty ^b,c   Carlin, John B ^b,c   Cheung, Michael ^a   Wilkinson, Lynette C ^a   Davis, Andrew M ^a   Kahler, Stephen G ^c,d   Chow, C W ^a   Wilkinson, James L ^a   Weintraub, Robert G ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b MURDOCH CHILDREN'S RESEARCH INSTITUTE   (Australia)

^c UNIVERSITY OF MELBOURNE   (Australia)

^d Genetic Health Services Victoria   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; AUSTRALIA; CARDIOMYOPATHY; CHILD; CHILDHOOD DISEASE; ETHNOLOGY; FEMALE; HEART DILATATION; HEREDITY; HISTOLOGY; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; INCIDENCE; INFANT; LEFT VENTRICULAR NONCOMPACTION; LYMPHOCYTIC MYOCARDITIS; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RESTRICTIVE CARDIOMYOPATHY; SUDDEN DEATH; SYMPTOM;

AGE DISTRIBUTION; AUSTRALIA; CARDIOMYOPATHIES; CHILD; CHILD, PRESCHOOL; COHORT STUDIES; FEMALE; HUMANS; INCIDENCE; INFANT; LYMPHOCYTES; MALE; MYOCARDITIS; RETROSPECTIVE STUDIES; SEX DISTRIBUTION;

EID: 0037464530     PISSN: 00284793     EISSN: None     Source Type: Journal    
DOI: 10.1056/NEJMoa021737     Document Type: Article

References (32)

1. Boucek MM, Farc, A, Novick RJ, Bennett LE, Keck BM, Hosenpud JD. The Registry of the International Society for Heart and Lung Transplantation: Fourth Official Pediatric Report - 2000. J Heart Lung Transplant 2001;20:39-52.
2. Matitiau A, Perez-Atayde A, Sanders SP, et al. Infantile dilated cardiomyopathy: relation of outcome to left ventricular mechanics, hemodynamics, and histology at the time of presentation. Circulation 1994;90: 1310-8.
3. Burch M, Siddiqi SA, Celermajer DS, Scott C, Bull C, Deanfield JE. Dilated cardiomyopathy in children: determinants of outcome. Br Heart J 1994;72:246-50.
4. Yetman AT, Hamilton RM, Benson LN, McCrindle BW. Long-term outcome and prognostic determinants in children with hypertrophic cardiomyopathy. J Am Coll Cardiol 1998;32;1943-50.
5. Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation 2000; 102:876-82.
6. Wiles HB, McArthur PD, Taylor AB, et al. Prognostic features of children with idiopathic dilated cardiomyopathy. Am J Cardiol 1991;68:1372-6.
7. Venugopalan P, Houston AB, Agarwal AK. The outcome of idiopathic dilated cardiomyopathy and myocarditis in children from the west of Scotland. Int J Cardiol 2001; 78:135-41.
8. Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of Cardiomyopathies. Circulation 1996;93:841-2.
9. Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium: a study of eight cases. Circulation 1990;82:507-13.
10. Colan SD, Parness IA, Spevak PJ, Sanders P. Developmental modulation of myocardial mechanics: age- and growth-related alterations in afterload and contractility J Am Coll Cardiol 1992;19:619-29.
11. Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis: a histopathologic definition and classification. Am J Cardiovasc Pathol 1987;1:3-14.
12. Estimated resident population by sex and age, states and territories of Australia, June 1987 to June 1992. Canberra: Australian Bureau of Statistics, 1993 (catalog no. 3201.0).
13. Population by age and sex, Australian states and territories, June 1992 to June 1997. Canberra: Australian Bureau of Statistics, 1997 (catalog no. 3201.0).
14. Experimental estimates of the Aboriginal and Torres Strait Islander population, June 1986 to June 1991. Canberra: Australian Bureau of Statistics, 1994 (catalog no. 3230.0).
15. Experimental estimates of the Aboriginal and Torres Strait Islander population, 30 June 1991-30 June 1996. Canberra: Australian Bureau of Statistics, 1998 (catalog no. 3230.0).
16. Stata statistical software: release 6.0. College Station, Tex.: Stata Corporation, 1999.
17. Ades LC, Gedeon AK, Wilson MJ, et al. Barth syndrome: clinical features and confirmation of gene localisation to distal Xq28. Am J Med Genet 1993;45:327-34.
18. Spirito P, Chiarella F, Carratino L, Berisso MZ, Bellotti P, Vecchio C. Clinical course and prognosis of hypertrophic cardiomyopathy in an outpatient population. N Engl J Med 1989;320:749-55.
19. Arola A, Jokinen E, Ruuskanen O, et al. Epidemiology of idiopathic cardiomyopathies in children and adolescents: a nationwide study in Finland. Am J Epidemiol 1997; 146:385-93.
20. Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis: rapid diagnosis by PCR in children. Circulation 1994;90:330-9.
21. Grenier MA, Osganian SK, Cox GF, et al. Design and implementation of the North American Pediatric Cardiomyopathy Registry. Am Heart J 2000;139:S86-S95.
22. Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med 2003;348:1647-55.
23. Maron BJ, Thompson PD, Puffer JC, et al. Cardiovascular preparticipation screening of competitive athletes: a statement for health professionals from the Sudden Death Committee (clinical cardiology) and Congenital Cardiac Defects Committee (cardiovascular disease in the young), American Heart Association. Circulation 1996;94:850-6.
24. Ferencz C, Neill CA. Cardiomyopathy in infancy: observations in an epidemiologic study. Pediatr Cardiol 1992;13:65-71.
25. Nugent AW, Davis AM, Kleinert S, Wilkinson JL, Weintraub RG. Clinical, electrocardiographic, and histologic correlations in children with dilated cardiomyopathy. J Heart Lung Transplant 2001;20:1152-7.
26. Bowles NE, Bowles KR, Towbin JA. The "final common pathway" hypothesis and inherited cardiovascular disease: the role of cytoskeletal proteins in dilated cardiomyopathy. Herz 2000;25:168-75.
27. Maron BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002;287: 1308-20.
28. Carapetis JR, Currie BJ. Mortality due to acute rheumatic fever and rheumatic heart disease in the Northern Territory: a preventable cause of death in aboriginal people. Aust N Z J Public Health 1999;23:159-63.
29. Mason JW, O'Connell JB, Herskowitz A, et al. A clinical trial of immunosuppressive therapy for myocarditis: The Myocarditis Treatment Trial Investigators. N Engl J Med 1995;333:269-75.
30. Pauschinger M, Bowles NE, Fuentes-Garcia FJ, et al. Detection of adenoviral genome in the myocardium of adult patients with idiopathic left ventricular dysfunction. Circulation 1999;99:1348-54.
31. Michels W, Moll PP, Mifler FA, et al. The frequency of familial dilated cardiomyopathy in a series of patients with idiopathic dilated cardiomyopathy. N Engl J Med 1992;326: 77-82.
32. Olson TM, Karst ML, Whitby FG, Driscoll DJ. Myosin light chain mutation causes autosomal recessive cardiomyopathy with mid-cavitary hypertrophy and restrictive physiology. Circulation 2002;105:2337-40.